𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences

✍ Scribed by Ginon, Isabelle; Decullier, Evelyne; Finet, Gerard; Cordier, Jean-Francois; Marion, Denis; Saurin, Jean-Christophe; Dupuis-Girod, Sophie

Book ID
121776574
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
180 KB
Volume
24
Category
Article
ISSN
0953-6205

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bevacizumab to treat complicated liver v
Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: A word of caution
✍ Elisabetta Buscarini; Guido Manfredi; Alessandro Zambelli πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 45 KB

We read with interest the article by Mitchell et al. 1 dealing with bevacizumab treatment of a patient with hereditary hemorrhagic telangiectasia (HHT), cardiac failure, and portal hypertension due to severe liver vascular malformations (VMs). The treatment reversed the need for liver transplantatio

Evaluation of previously nonscreened her
Evaluation of previously nonscreened hereditary hemorrhagic telangiectasia patients shows frequent liver involvement and early cardiac consequences
✍ Rodica Gincul; Gaetan Lesca; BΓ©nΓ©dicte Gelas-Dore; Nathalie Rollin; Martine Bart πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

Hereditary hemorrhagic telangiectasia (HHT) is a genetic disease characterized by cutaneous, mucosal, and sometimes visceral arteriovenous malformations. Severe hepatic manifestations have been characterized in a subgroup of patients, but few data are available in previously nonscreened patients. We